[CAS NO. 199331-35-6]  Dehydroglyasperin C

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [199331-35-6]

Store
Catalog
AS164011
Brand
Arctom Scientific
CAS
199331-35-6

DESCRIPTION [199331-35-6]

Overview

MDL-
Molecular Weight354.40
Molecular FormulaC21H22O5
SMILESOC1=CC=C(C2=CC3=C(OC)C(C/C=C(C)\C)=C(O)C=C3OC2)C(O)=C1

For research use only. We do not sell to patients.

Summary

Dehydroglyasperin C, a isoflavone, is a potent NAD(P)H:oxidoquinone reductase (NQO1) and phase 2 enzyme inducer. Dehydroglyasperin C has antioxidant, neuroprotective, cancer chemopreventive, and anti-inflammatory activities [1] [2] [3] .


In Vitro

Dehydroglyasperin C (0.1-1 μM; 24 h) blocks the PDGF-induced progression through the G0/G1 to S phase of the cell cycle, and down-regulates the expression of CDK; 2, cyclin E, CDK4 and cyclin D1. Dehydroglyasperin C significantly attenuates PDGF-stimulated phosphorylation of PDGF receptor-β, phospholipase C-γ1, AKT and extracellular-regulated kinase 1/2, and DGC inhibits cell migration and the dissociation of actin filaments by PDGF [1] .
Dehydroglyasperin C (0.1-1 μM; 24 h) treatment significantly decreases PDGF-induced cell number and DNA synthesis in a dose-dependent manner without any cytotoxicity in human aortic smooth muscle cells (HASMC) [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis [1]

Cell Line: Human aortic smooth muscle cells (HASMC)
Concentration: 0.1 μM, 0.5 μM, 1 μM
Incubation Time: 24 hours
Result: Blocked the PDGF-induced progression through the G0/G1 to S phase of the cell cycle.

Western Blot Analysis [1]

Cell Line: Human aortic smooth muscle cells (HASMC)
Concentration: 0.1 μM, 0.5 μM, 1 μM
Incubation Time: 24 hours
Result: Down-regulated the expression of CDK; 2, cyclin E, CDK4 and cyclin D1.

In Vivo

In ICR mice, Dehydroglyasperin C (5 mg/kg; once) combined with CCl4 shows reduced lipid droplet formation in liver tissue, as assessed by histological examination. Further, DGC demonstrated a slight protective effect against centrilobular injury caused by CCl4 injection, perhaps through suppression of CYP2E1 expression [4] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.



Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.